WO2001062901A3 - Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof - Google Patents

Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof Download PDF

Info

Publication number
WO2001062901A3
WO2001062901A3 PCT/US2001/006106 US0106106W WO0162901A3 WO 2001062901 A3 WO2001062901 A3 WO 2001062901A3 US 0106106 W US0106106 W US 0106106W WO 0162901 A3 WO0162901 A3 WO 0162901A3
Authority
WO
WIPO (PCT)
Prior art keywords
derived stromal
adipose tissue
stem cells
stromal cells
pleuripotent stem
Prior art date
Application number
PCT/US2001/006106
Other languages
French (fr)
Other versions
WO2001062901A2 (en
Inventor
William O Wilkison
Jeffrey Gimble
Original Assignee
Artecel Sciences Inc
William O Wilkison
Jeffrey Gimble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artecel Sciences Inc, William O Wilkison, Jeffrey Gimble filed Critical Artecel Sciences Inc
Priority to JP2001562675A priority Critical patent/JP2003523767A/en
Priority to AU3869501A priority patent/AU3869501A/en
Priority to DK01911175T priority patent/DK1261694T3/en
Priority to CA2400485A priority patent/CA2400485C/en
Priority to DE60132429T priority patent/DE60132429T2/en
Priority to AU2001238695A priority patent/AU2001238695B2/en
Priority to EP01911175A priority patent/EP1261694B1/en
Publication of WO2001062901A2 publication Critical patent/WO2001062901A2/en
Publication of WO2001062901A3 publication Critical patent/WO2001062901A3/en
Priority to IL151228A priority patent/IL151228A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1384—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention is in the area of pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof. In particular, the invention includes isolated adipose tissue derived stromal cells that have been induced to express at least one phenotypic characteristic of a neuronal, astroglial, hematopoietic progenitor, or hepatic cell. The invention also includes an isolated adipocyte tissue-derived stromal cell that has been dedifferentiated such that there is an absence of adipocyte phenotypic markers.
PCT/US2001/006106 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof WO2001062901A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2001562675A JP2003523767A (en) 2000-02-26 2001-02-26 Pluripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
AU3869501A AU3869501A (en) 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
DK01911175T DK1261694T3 (en) 2000-02-26 2001-02-26 Pluripotent stem cells generated from stromal cells derived from adipose tissue as well as applications thereof
CA2400485A CA2400485C (en) 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
DE60132429T DE60132429T2 (en) 2000-02-26 2001-02-26 PLURIPOTENTS FROM FAT-FROZEN-GENERIC STROMA CELLS GENERATED STRAIN CELLS AND THEIR USE
AU2001238695A AU2001238695B2 (en) 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
EP01911175A EP1261694B1 (en) 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
IL151228A IL151228A (en) 2000-02-26 2002-08-13 Isolated, differentiated adipose tissue-derived stromal cells and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18533800P 2000-02-26 2000-02-26
US60/185,338 2000-02-26

Publications (2)

Publication Number Publication Date
WO2001062901A2 WO2001062901A2 (en) 2001-08-30
WO2001062901A3 true WO2001062901A3 (en) 2002-02-21

Family

ID=22680577

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/006106 WO2001062901A2 (en) 2000-02-26 2001-02-26 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof

Country Status (13)

Country Link
US (2) US7078230B2 (en)
EP (1) EP1261694B1 (en)
JP (1) JP2003523767A (en)
AT (1) ATE384124T1 (en)
AU (2) AU2001238695B2 (en)
CA (1) CA2400485C (en)
DE (1) DE60132429T2 (en)
DK (1) DK1261694T3 (en)
ES (1) ES2300320T3 (en)
IL (1) IL151228A (en)
PT (1) PT1261694E (en)
SG (1) SG134168A1 (en)
WO (1) WO2001062901A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691216B2 (en) 2001-12-07 2014-04-08 Cytori Therapeutics, Inc. Methods of using regenerative cells to promote wound healing
US8883499B2 (en) 2001-12-07 2014-11-11 Cytori Therapeutics, Inc. Systems and methods for isolating and using clinically safe adipose derived regenerative cells
US9133431B2 (en) 2009-05-01 2015-09-15 Bimini Technologies Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts
US9198937B2 (en) 2001-12-07 2015-12-01 Cytori Therapeutics, Inc. Adipose-derived regenerative cells for treating liver injury
US9463203B2 (en) 2001-12-07 2016-10-11 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of cartilage defects
US9480718B2 (en) 2001-12-07 2016-11-01 Cytori Therapeutics, Inc. Methods of using adipose-derived regenerative cells in the treatment of peripheral vascular disease and related disorders
US9486484B2 (en) 2008-08-19 2016-11-08 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1615599A (en) 1997-12-02 1999-06-16 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
US20050153442A1 (en) * 1999-03-10 2005-07-14 Adam Katz Adipose-derived stem cells and lattices
US20050076396A1 (en) * 1999-03-10 2005-04-07 Katz Adam J. Adipose-derived stem cells and lattices
KR100870508B1 (en) * 1999-03-10 2008-11-25 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 Adipose-derived stem cells and lattices
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
DK1226233T3 (en) * 1999-08-05 2011-10-03 Abt Holding Co Multipotent adult stem cells and methods for isolation thereof
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7582292B2 (en) * 2000-02-26 2009-09-01 Artecel, Inc. Adipose tissue derived stromal cells for the treatment of neurological disorders
PT1261694E (en) * 2000-02-26 2008-04-03 Artecel Inc Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
US6673606B1 (en) * 2000-04-12 2004-01-06 The Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
US7282366B2 (en) 2000-04-27 2007-10-16 Geron Corporation Hepatocytes for therapy and drug screening made from embryonic stem cells
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
US7256042B2 (en) 2000-04-27 2007-08-14 Geron Corporation Process for making hepatocytes from pluripotent stem cells
FR2819265B1 (en) * 2001-01-10 2004-01-02 Centre Nat Rech Scient EXTRAMEDULAR ADIPOSE TISSUE CELLS AND THEIR APPLICATIONS IN THE RECONSTRUCTION OF HEMATOPOIETIC LINES
JP2004529621A (en) 2001-02-14 2004-09-30 ティー ファークト，レオ Pluripotent adult stem cells, their origin, methods of obtaining and maintaining them, methods of differentiating them, methods of their use, and cells derived therefrom
DE10144326B4 (en) * 2001-09-10 2005-09-22 Siemens Ag Method and system for monitoring a tire air pressure
EP1451300A4 (en) * 2001-11-09 2007-01-10 Artecel Sciences Inc Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
JP2005533480A (en) * 2001-11-09 2005-11-10 アーテセル・サイエンシズ・インコーポレーテツド Pancreatic endocrine differentiation of adipose tissue-derived stromal cells and use thereof
CA2465908A1 (en) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
AU2003220424A1 (en) * 2002-03-19 2003-10-08 Advanced Research And Technology Transfer Adipose stromal stem cells for tissue and vascular modification
EP1496978A4 (en) * 2002-04-03 2006-11-29 Artecel Sciences Inc Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
EP1513926A4 (en) * 2002-05-24 2006-08-02 Cytomatrix Llc Cytokine-free growth and maintenance of progenitor cells
AU2003298016A1 (en) 2002-11-27 2004-06-23 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
FR2850009B1 (en) * 2003-01-20 2005-12-23 Spine Next Sa TREATMENT ASSEMBLY FOR THE DEGENERATION OF AN INTERVERTEBRAL DISC
US20040193274A1 (en) * 2003-03-28 2004-09-30 Trieu Hai H. Materials and methods for augmenting and/or repairing intervertebral discs
JP4749331B2 (en) 2003-10-07 2011-08-17 株式会社バイオマスター Cell differentiation of adipose-derived progenitor cells
SG146691A1 (en) 2003-10-08 2008-10-30 Vet Stem Inc Methods of preparing and using stem cell compositions and kits comprising the same
NZ581804A (en) * 2003-10-22 2011-10-28 Encelle Inc Bioactive hydrogel compositions for regenerating connective tissue
US9631176B2 (en) 2003-11-04 2017-04-25 Biomaster, Inc. Method for preparing stem cells from fat tissue
EP2298862B1 (en) 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2005093083A1 (en) * 2004-03-29 2005-10-06 Kazuhisa Maeda Method of disease prediction and method of using the same
JP2007252393A (en) * 2004-04-28 2007-10-04 Nippon Medical School Composition and method for forming marrow from fat tissue derived stem cell
WO2006014156A1 (en) * 2004-07-02 2006-02-09 Macropore Biosurgery, Inc. Systems and methods for isolating and using clinically safe adipose derived regenerative cells
ES2313805B1 (en) * 2004-10-04 2009-12-23 Cellerix, S.L. IDENTIFICATION AND ISOLATION OF MULTIPOTENT CELLS OF NON-OSTEOCONDRAL MESENQUIMAL FABRIC.
US20060051865A1 (en) * 2004-08-31 2006-03-09 Higgins Joel C Systems and methods for isolating stromal cells from adipose tissue and uses thereof
WO2006046583A1 (en) * 2004-10-26 2006-05-04 Santen Pharmaceutical Co., Ltd. Material for regenerating visual cells or functions thereof
JP5138384B2 (en) * 2005-01-10 2013-02-06 サイトリ セラピューティクス インコーポレイテッド Apparatus and method for monitoring, managing and servicing medical devices
MX2007009173A (en) * 2005-01-31 2008-03-10 Cognate Therapeutics Inc Adipose derived adult stromal cells exhibiting characteristics of endothelial cells.
EP2428563A1 (en) * 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
WO2006121454A2 (en) * 2005-05-05 2006-11-16 Regents Of The University Of Minnesota Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
WO2006128029A2 (en) * 2005-05-25 2006-11-30 University Of Virginia Patent Foundation Production of osteoclasts from adipose tissues
US20080194024A1 (en) * 2005-07-29 2008-08-14 Mays Robert W Culture of Non-Embryonic Cells at High Cell Density
US7531355B2 (en) * 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
WO2007030469A2 (en) * 2005-09-06 2007-03-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Transplantable cell growth niche and related compositions and methods
NZ567082A (en) * 2005-10-14 2012-08-31 Univ Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US20070104692A1 (en) * 2005-11-07 2007-05-10 Quijano Rodolfo C Breast tissue regeneration
WO2007055882A2 (en) * 2005-11-07 2007-05-18 Hosheng Tu Breast augmentation and reconstruction system
US20070104693A1 (en) * 2005-11-07 2007-05-10 Quijano Rodolfo C Breast augmentation system
KR100679642B1 (en) 2005-11-16 2007-02-06 주식회사 알앤엘바이오 Multipotent stem cell derived from human adipose tissue and cellular therapeutic agents comprising the same
FR2896511B1 (en) * 2006-01-26 2012-10-26 Centre Nat Rech Scient PROCESS FOR CULTIVATION OF CELLS FROM ADIPOSE TISSUE AND THEIR APPLICATIONS
US8592209B2 (en) * 2006-01-30 2013-11-26 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
US20090175835A1 (en) * 2006-02-07 2009-07-09 Korea Institute Of Radiological & Medical Sciences Composition for treating damage of central or peripheral nerve system
PT2366775E (en) 2006-03-23 2015-07-20 Pluristem Ltd Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
JP2009535035A (en) * 2006-04-25 2009-10-01 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ Adipocyte-derived adult stem cells in liver regeneration
WO2007136424A2 (en) 2006-05-17 2007-11-29 Cognate Therapeutics, Inc. Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
FR2901136B1 (en) * 2006-05-18 2010-10-01 Centre Nat Rech Scient USE OF CELLS DERIVED FROM ADIPOSE TISSUE FOR THE PREPARATION OF AN ANTI-TUMOR DRUG
WO2007139551A1 (en) * 2006-05-30 2007-12-06 Cytori Therapeutics, Inc. Systems and methods for manipulation of regenerative cells from adipose tissue
EP2024492B1 (en) 2006-06-02 2017-03-29 Asterias Biotherapeutics, Inc. Differentiation of primate pluripotent cells to hepatocyte-lineage cells
FR2902011B1 (en) * 2006-06-12 2008-12-26 Inst Radioprot Et De Surete Nu USE OF CELLULAR FRACTIONS OF ADIPOSE TISSUE FOR POST IRRADIATION TISSUE REGENERATION
WO2007145438A1 (en) * 2006-06-15 2007-12-21 Rnl Bio Co., Ltd Cosmetic or plastic composition comprising multipotent stem cells derived from human adipose tissue, fibroblast, and adipose or adiopocyte
WO2008013863A2 (en) * 2006-07-26 2008-01-31 Cytori Therapeutics, Inc. Generation of adipose tissue and adipocytes
JP2010505849A (en) * 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション Methods and compositions useful for diabetic wound healing
US8172784B2 (en) * 2006-10-11 2012-05-08 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
WO2008063675A2 (en) * 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
US20090317367A1 (en) * 2007-02-21 2009-12-24 Cedars-Sinai Medical Center Methods of producing preadipocytes and increasing the proliferation of adult adipose stem/progenitor cells
WO2008132722A1 (en) * 2007-04-26 2008-11-06 Ramot At Tel-Aviv University Ltd. Pluripotent autologous stem cells from oral mucosa and methods of use
SI2200622T2 (en) 2007-09-19 2015-09-30 Pluristem Ltd. Adherent cells from adipose or placenta tissues and use thereof in therapy
US8273091B2 (en) * 2007-10-04 2012-09-25 Ebi, Llc Alignment device for locking nail
WO2009069991A2 (en) * 2007-11-30 2009-06-04 Rnl Bio Co., Ltd. Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose
AU2009205886B2 (en) 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
US9422522B2 (en) 2008-02-05 2016-08-23 Regenertech Pty Limited Method of producing adipocytes from fibroblast cells
CN102123717A (en) 2008-05-27 2011-07-13 普拉里斯坦有限公司 Methods of treating inflammatory colon diseases
EP2334783B1 (en) 2008-09-02 2016-06-22 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
US9057051B2 (en) 2008-10-31 2015-06-16 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells
US20120282228A1 (en) * 2009-07-15 2012-11-08 Vishal Bhasin Method of producing progenitor cells from differentiated cells
AU2010276201B2 (en) * 2009-07-21 2013-10-17 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
DK2456860T3 (en) * 2009-07-21 2019-01-07 Abt Holding Co USE OF STEM CELLS FOR REDUCING LEUKOCYTE EXTRAVASATION
US20110027239A1 (en) * 2009-07-29 2011-02-03 Tissue Genesis, Inc. Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer
US9173903B2 (en) * 2009-08-17 2015-11-03 Ashok K. Singh Fluid associated with adult stem cells for medical, cosmetic, and veterinary use
EP2507362A2 (en) 2009-11-30 2012-10-10 Pluristem Ltd. Adherent cells from placenta and use of same in disease treatment
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US9447379B2 (en) 2010-02-27 2016-09-20 Reza Izadpanah Derivation of hematopoietic cells from adult mesenchymal stem cells
EP2568991B3 (en) 2010-05-12 2018-11-28 ABT Holding Company Modulation of splenocytes in cell therapy
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
WO2013106655A1 (en) 2012-01-11 2013-07-18 The Gid Group, Inc. Method for processing adipose tissue and processing apparatus
US9206387B2 (en) 2010-07-09 2015-12-08 The Gid Group, Inc. Method and apparatus for processing adipose tissue
EP3366327B1 (en) 2010-07-09 2022-09-21 GID BIO, Inc. Apparatus and methods relating to collecting and processing human biological material containing adipose
US9296984B2 (en) 2010-07-09 2016-03-29 The Gid Group, Inc. Tissue processing apparatus and method for processing adipose tissue
WO2012009830A1 (en) * 2010-07-22 2012-01-26 宁夏医科大学附属医院 Methods for producing nerve cells from stem cells, nerve cells and uses thereof
EP2609191B1 (en) 2010-08-24 2017-11-22 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
JP5804342B2 (en) * 2010-09-11 2015-11-04 国立大学法人金沢大学 Therapeutic agent for hepatitis including adipose tissue-derived stromal cells
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US8440440B2 (en) 2010-12-27 2013-05-14 Intellicell Biosciences Inc. Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof
EP2689008B1 (en) 2011-03-22 2017-09-27 Pluristem Ltd. Methods for treating radiation or chemical injury
US9657266B2 (en) 2011-04-15 2017-05-23 Pluristem Ltd. Methods and systems for harvesting cells
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CN102433299B (en) * 2011-11-17 2013-01-23 安徽农业大学 Method for separating, culturing and purifying mouse adipose-derived stem cells
US9512405B2 (en) 2011-12-14 2016-12-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Non-enzymatic method for isolating human adipose-derived stromal stem cells
CA2860227C (en) 2011-12-23 2020-03-24 Pioneer Surgical Technology Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
CA2882687A1 (en) 2012-09-04 2014-03-13 Pluristem Ltd. Methods for prevention and treatment of preeclampsia
EP3075841B1 (en) 2012-09-06 2021-03-10 GID BIO, Inc. Tissue processing apparatus and method for processing adipose tissue
WO2014089554A1 (en) * 2012-12-07 2014-06-12 Antria, Inc. Formulations containing and kit for using adipose-derived stem cells and use thereof
US9650608B2 (en) 2013-02-22 2017-05-16 Medivet America, Llc Activating adipose-derived stem cells for transplantation
CN105338989B (en) 2013-04-12 2022-04-08 赛维里奥·拉弗朗切西卡 Improvements in organs for transplantation
WO2014190150A1 (en) 2013-05-22 2014-11-27 The Regents Of The University Of California Pluripotent human adipose adult stem cells: isolation, characterization and clinical implications
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US20150037303A1 (en) * 2013-08-01 2015-02-05 Regen Biopharma, Inc Cells, compositions, and treatment methods for stimulation of hematopoiesis
EP3038629B1 (en) 2013-09-05 2020-11-18 GID BIO, Inc. Method for processing adipose tissue
US9617506B2 (en) 2013-11-16 2017-04-11 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
US10258652B2 (en) 2014-12-18 2019-04-16 Pluristem Ltd. Methods and compositions for treating and preventing muscle wasting disorders
IL294058A (en) 2015-03-23 2022-08-01 Pluristem Ltd Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
NZ745530A (en) 2016-01-21 2023-03-31 Abt Holding Co Stem cells for wound healing
IL261146B (en) 2016-02-18 2022-07-01 Pluristem Ltd Methods and compositions for treating cancers and neoplasms
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3506957A1 (en) 2016-08-30 2019-07-10 LifeCell Corporation Systems and methods for medical device control
USD851777S1 (en) 2017-01-30 2019-06-18 Lifecell Corporation Canister-type device for tissue processing
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN106834259A (en) * 2017-04-14 2017-06-13 青岛青春派生物科技有限公司 A kind of human fat tissue digestive ferment and preparation method thereof
IL270114B2 (en) 2017-04-24 2024-01-01 Pluri Biotech Ltd Methods and compositions for treating neurological disorders
WO2019018002A1 (en) 2017-07-18 2019-01-24 The Gid Group, Inc. Adipose tissue digestion system and tissue processing method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028444A1 (en) * 1997-12-02 1999-06-10 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
WO2000044882A2 (en) * 1999-01-29 2000-08-03 Zen-Bio, Inc. Methods and compositions for the differentiation of human preadipocytes into adipocytes
WO2000053795A1 (en) * 1999-03-10 2000-09-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5759830A (en) 1986-11-20 1998-06-02 Massachusetts Institute Of Technology Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
IL95429A (en) 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
NO171069C (en) 1990-05-29 1993-01-20 Protan Biopolymer As COVALENT CIRCUIT, STRONGLY SWELLING ALKALIMETAL AND AMMONIUM ALGINATE GELS, AND PROCEDURES FOR PREPARING THEREOF
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US6176874B1 (en) 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US6103522A (en) 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5516532A (en) 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US6123727A (en) 1995-05-01 2000-09-26 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5741685A (en) 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
WO1997015655A2 (en) 1995-10-20 1997-05-01 Michael Sittinger New artificial tissue, method for the production and the use thereof
DE69631490T2 (en) 1995-11-09 2004-10-07 Univ Massachusetts Boston RESTORATION OF TISSUE SURFACE WITH COMPOSITIONS FROM HYDROGEL CELLS
JP3781433B2 (en) 1995-11-16 2006-05-31 ケース ウエスターン リザーブ ユニバーシティ In vitro chondrogenesis induction of human mesenchymal stem cells
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5965436A (en) 1996-11-15 1999-10-12 Osiris Therapeutics, Inc. Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes
US5786207A (en) 1997-05-28 1998-07-28 University Of Pittsburgh Tissue dissociating system and method
US6027744A (en) 1998-04-24 2000-02-22 University Of Massachusetts Medical Center Guided development and support of hydrogel-cell compositions
JP5546084B2 (en) * 1998-05-26 2014-07-09 オプサニテクス エルエルシー Compositions and methods for modulating an immune response to an antigen
EP1082410B1 (en) 1998-05-29 2007-08-01 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
EP1108011A2 (en) 1998-06-08 2001-06-20 Osiris Therapeutics, Inc. In vitro maintenance of hematopoietic stem cells
US6555374B1 (en) * 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
EP1218489B1 (en) 1999-09-24 2009-03-18 Cybios LLC Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
PT1261694E (en) * 2000-02-26 2008-04-03 Artecel Inc Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
EP1152058A1 (en) * 2000-05-03 2001-11-07 Institut Curie Methods and compositions for effecting homologous recombination

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028444A1 (en) * 1997-12-02 1999-06-10 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
WO2000044882A2 (en) * 1999-01-29 2000-08-03 Zen-Bio, Inc. Methods and compositions for the differentiation of human preadipocytes into adipocytes
WO2000053795A1 (en) * 1999-03-10 2000-09-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Adipose-derived stem cells and lattices

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BJORNSON C R R ET AL: "Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo", SCIENCE, vol. 283, no. 5401, 22 January 1999 (1999-01-22), pages 534 - 537, XP002162102 *
DARMON M ET AL: "5-azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelial cells", EMBO JOURNAL, vol. 3, no. 5, 1984, pages 961 - 968, XP001024628 *
JACKSON K A ET AL: "Hematopoietic potential of stem cells isolated from murine skeletal muscle", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 96, no. 25, 7 December 1999 (1999-12-07), pages 14482 - 14486, XP002161311 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691216B2 (en) 2001-12-07 2014-04-08 Cytori Therapeutics, Inc. Methods of using regenerative cells to promote wound healing
US8883499B2 (en) 2001-12-07 2014-11-11 Cytori Therapeutics, Inc. Systems and methods for isolating and using clinically safe adipose derived regenerative cells
US9198937B2 (en) 2001-12-07 2015-12-01 Cytori Therapeutics, Inc. Adipose-derived regenerative cells for treating liver injury
US9463203B2 (en) 2001-12-07 2016-10-11 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of cartilage defects
US9480718B2 (en) 2001-12-07 2016-11-01 Cytori Therapeutics, Inc. Methods of using adipose-derived regenerative cells in the treatment of peripheral vascular disease and related disorders
US9492483B2 (en) 2001-12-07 2016-11-15 Cytori Therapeutics, Inc. Methods of using regenerative cells to treat a burn
US9504716B2 (en) 2001-12-07 2016-11-29 Cytori Therapeutics, Inc. Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc
US9511096B2 (en) 2001-12-07 2016-12-06 Cytori Therapeutics, Inc. Methods of using regenerative cells to treat an ischemic wound
US9486484B2 (en) 2008-08-19 2016-11-08 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US9133431B2 (en) 2009-05-01 2015-09-15 Bimini Technologies Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts

Also Published As

Publication number Publication date
DK1261694T3 (en) 2008-05-26
EP1261694B1 (en) 2008-01-16
CA2400485A1 (en) 2001-08-30
ATE384124T1 (en) 2008-02-15
DE60132429T2 (en) 2009-01-08
SG134168A1 (en) 2007-08-29
US7078230B2 (en) 2006-07-18
IL151228A (en) 2013-05-30
AU2001238695B2 (en) 2005-11-24
WO2001062901A2 (en) 2001-08-30
EP1261694A2 (en) 2002-12-04
ES2300320T3 (en) 2008-06-16
PT1261694E (en) 2008-04-03
CA2400485C (en) 2014-04-29
US20060228341A1 (en) 2006-10-12
JP2003523767A (en) 2003-08-12
US20010033834A1 (en) 2001-10-25
AU3869501A (en) 2001-09-03
DE60132429D1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
WO2001062901A3 (en) Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
WO2004069172A3 (en) Multilineage-inducible cells and uses thereof
WO2005047524A3 (en) Compositions and methods for inducing cell dedifferentiation
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
WO2000031238A3 (en) Methods and reagents for increasing proliferative capacity and preventing replicative senescence
GB2427874A (en) Differentiation of stem cells to endoderm and pancreatic lineage
WO1999064566A8 (en) In vitro maintenance of hematopoietic stem cells
EP1536556A3 (en) Switching amplifier architecture
AU2002319054A1 (en) Multipotent stem cells from peripheral tissues and uses thereof
WO2003012061A3 (en) Methods and compositions relating to plasmacytoid dendritic cells
AU5488501A (en) Modified es cells and es cell-specific gene
EP1401869A4 (en) Molecules and methods for inhibiting shedding of kim-1
AU2002363372A1 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
AU2002246792A1 (en) Identification of individual cells during kinetic assays
AU3036797A (en) Immortal avian cells
WO2002072866A3 (en) Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma
HK1044190A1 (en) A method for identifying pre-neoplastic and/or neoplastic states in mammals
AUPR201500A0 (en) Methods for identifying pre-neoplastic and neoplastic states in mammals
EP1119581A4 (en) METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
WO2002051988A3 (en) Thymic epithelial progenitor cells and uses thereof
ITVE20030021A1 (en) DOWNHILL SKIING.
HUP0101393A1 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
WO2003083057A3 (en) Adipocytes and uses thereof
GB2398079A (en) Characterization and isolation of subsets of human embryonic stem cells (HES) and cells associated or derived therefrom
WO2002033043A3 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 151228

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001238695

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2400485

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 562675

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001911175

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001911175

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001238695

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001911175

Country of ref document: EP